Table 2.
Overall | Whites | African Americans | |||||||
---|---|---|---|---|---|---|---|---|---|
n | Δ LDL-C (mg/dL) | Δ TC (mg/dL) | n | Δ LDL-C (mg/dL) | Δ TC (mg/dL) | N | Δ LDL-C (mg/dL) | Δ TC (mg/dL) | |
CYP3A4 | |||||||||
*1/*1 | 864 | −54 ± 22 | −57 ± 24 | 561 | −56 ± 21 | −59 ± 23 | 303 | −51 ± 24 | −53 ± 25 |
*1/*22 | 54 | −56 ± 23 | −60 ± 26 | 46 | −58 ± 21 | −62 ± 23 | 8 | −44 ± 29 | −50 ± 38 |
†p-value | 0.816 | 0.444 | 0.489 | 0.307 | 0.376 | 0.742 | |||
‡p-value | 0.898 | 0.726 | 0.901 | 0.783 | 0.820 | 0.963 | |||
CYP3A5 | |||||||||
*1/*1 | 125 | −49 ± 25 | −51 ± 24 | 6 | −56 ± 17 | −57 ± 16 | 119 | −48 ± 25 | −51 ± 25 |
*1/*3 | 216 | −53 ± 22 | −55 ± 24 | 73 | −56 ± 20 | −58 ± 22 | 143 | −51 ± 24 | −53 ± 25 |
*3/*3 | 537 | −57 ± 21 | −59 ± 23 | 507 | −57 ± 21 | −59 ± 23 | 30 | −53 ± 21 | −57 ± 25 |
†p-value | 0.464 | 0.328 | 0.507 | 0.414 | 0.832 | 0.683 | |||
‡p-value | 0.726 | 0.669 | 0.901 | 0.828 | 0.972 | 0.963 | |||
SLCO1B1 | |||||||||
C/C | 14 | −44 ± 25 | −43 ± 27 | 14 | −44 ± 25 | −43 ± 27 | 0 | - | - |
C/T | 151 | −55 ± 19 | −58 ± 21 | 137 | −55 ± 19 | −57 ± 21 | 14 | −57 ± 20 | −60 ± 23 |
T/T | 718 | −55 ± 22 | −58 ± 24 | 441 | −57 ± 22 | −60 ± 24 | 277 | −51 ± 23 | −54 ± 25 |
†p-value | 0.103 | 0.028 | 0.038 | 0.008 | 0.310 | 0.305 | |||
‡p-value | 0.495 | 0.204 | 0.366 | 0.107 | 0.783 | 0.783 |
ΔLDL-C = change in low-density lipoprotein cholesterol. Δ TC = change in total cholesterol. CYP3A4 = the gene encoding cytochrome P450, family 3, subfamily A, polypeptide 4. CYP3A5 = the gene encoding cytochrome P450, family 3, subfamily A, polypeptide 5. SLCO1B1 = the gene encoding solute carrier organic anion transporter family member 1B1.
Adjusted for age, smoking status, genetic ancestry (first 3 multi-dimensional scaling components) and self-reported race (when applicable);
also corrected for multiple comparisons with a false discovery rate of 5%. Values are presented as mean ± standard deviation. Only p-values < 0.05 are bolded.